imodium and tirzepatide What antidiarrheal medication should be prescribed for a patient experiencing watery diarrhea from (Mounjaro) weight‑loss therapy? Tirzepatide Research Compound | Axiom

These markers track metabolic response and ensure safe dose escalation

( b-e ) Body weight ( b ), circulating glucose ( c ), BHB ( d ) and insulin ( e ) in male and female mice fed CD, HFD, or KD over the experimental timeline

*Tres Chimbadas Lake

a Local Coverage Determination (LCD) policy or Article ID

REDEFINE 1 -- CagriSema phase 3 (Aronne et al., 2025): CagriSema 2.4/2.4 mg produced 22.7% mean weight loss at 68 weeks vs 2.1% placebo

Among neonates, 60%74% undergoing ECMO have AKI and, in a cohort study of adults treated with ECMO (92), the estimated incidence of AKI and severe AKI requiring renal replacement therapy (RRT) was 62.8% and 44.9% (93), respectively